FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285266642> ?p ?o ?g. }

• W4285266642 endingPage "205031212211044" @default.
• W4285266642 startingPage "205031212211044" @default.
• W4285266642 abstract "Sustained adherence to highly active antiretroviral therapy is necessary to suppress viral replication and improve immunological and clinical outcomes. Although different studies tried to identify factors affecting adherence to highly active antiretroviral therapy, there are few studies after initiation of test and start strategy and the first-line drug regimen change in the study area. Therefore, this study aimed to determine the level of adherence to highly active antiretroviral therapy and associated factors among people living with HIV in Eastern Ethiopia.Institutional-based cross-sectional study design was conducted from 2 March 2020, to 30 March 2020. A total of 501 study participants were recruited using systematic random sampling. Data were collected using face-to-face interviews at the end of the clinic visit and a review of participants' medical records. The level of adherence to highly active antiretroviral therapy was measured using the eight-item Morisky Medication Adherence Scale. The score ranges from 0 to 8, and a score of less than 8 indicates poor adherence. The data were entered into EpiData and exported to STATA for further analysis. The binary logistic regression analysis model was employed to identify associated factors. The association was reported with an adjusted odds ratio and a 95% confidence level. The significance level was declared at p = 0.05.A total of 501 participants participated in the study, giving a response rate of 98.2%. The majority (314 or 62.7%) of study participants were females. The participants' mean (standard deviation) age was 38.17 (8.75). The level of poor adherence to highly active antiretroviral therapy was found to be 33.73% (confidence interval: 29.70, 38.00). Age category 35 to 44 (1.65 (confidence interval: 1.02, 2.69)), no shortage of highly active antiretroviral therapy (0.46 (confidence interval: 0.28, 0.75)), substance use (1.67 (confidence interval: 1.11, 2.25)), having moderate depressive symptoms (4.00 (confidence interval: 1.94, 8.48)), and moderate anxiety symptoms (5.22 (confidence interval: 2.31, 8.84)) were significantly associated with the poor adherence to highly active antiretroviral therapy among adult people living with HIV.The level of poor adherence to highly active antiretroviral therapy was found to be high in this study. Poor adherence to highly active antiretroviral therapy was significantly associated with age, availability of highly active antiretroviral therapy drugs, substance usage, depressive symptoms, and anxiety symptoms. Improving the adherence levels requires stringent counseling, assuring continuous drug availability, and timely screening and management of depression and anxiety." @default.
• W4285266642 created "2022-07-14" @default.
• W4285266642 creator A5021361572 @default.
• W4285266642 creator A5030304171 @default.
• W4285266642 creator A5036946045 @default.
• W4285266642 creator A5061330434 @default.
• W4285266642 creator A5076303798 @default.
• W4285266642 creator A5084634315 @default.
• W4285266642 date "2022-01-01" @default.
• W4285266642 modified "2023-10-14" @default.
• W4285266642 title "Poor adherence to highly active antiretroviral therapy and associated factors among people living with HIV in Eastern Ethiopia" @default.
• W4285266642 cites W1414542444 @default.
• W4285266642 cites W1524366138 @default.
• W4285266642 cites W1723129825 @default.
• W4285266642 cites W1963543274 @default.
• W4285266642 cites W1963640452 @default.
• W4285266642 cites W1966242613 @default.
• W4285266642 cites W1976594536 @default.
• W4285266642 cites W1980514758 @default.
• W4285266642 cites W1980638765 @default.
• W4285266642 cites W1988367507 @default.
• W4285266642 cites W2010696953 @default.
• W4285266642 cites W2012471000 @default.
• W4285266642 cites W2035535532 @default.
• W4285266642 cites W2043705607 @default.
• W4285266642 cites W2077020785 @default.
• W4285266642 cites W2101700455 @default.
• W4285266642 cites W2110386233 @default.
• W4285266642 cites W2118723136 @default.
• W4285266642 cites W2140747910 @default.
• W4285266642 cites W2150490647 @default.
• W4285266642 cites W2164099498 @default.
• W4285266642 cites W2220190316 @default.
• W4285266642 cites W2257433733 @default.
• W4285266642 cites W2418625878 @default.
• W4285266642 cites W2505913877 @default.
• W4285266642 cites W2505970350 @default.
• W4285266642 cites W2769261452 @default.
• W4285266642 cites W2810057704 @default.
• W4285266642 cites W2883003988 @default.
• W4285266642 cites W2959737187 @default.
• W4285266642 cites W2965365748 @default.
• W4285266642 cites W3010531378 @default.
• W4285266642 cites W3020560518 @default.
• W4285266642 cites W3106806603 @default.
• W4285266642 cites W3165356376 @default.
• W4285266642 cites W3196355064 @default.
• W4285266642 cites W4200635487 @default.
• W4285266642 doi "https://doi.org/10.1177/20503121221104429" @default.
• W4285266642 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35769492" @default.
• W4285266642 hasPublicationYear "2022" @default.
• W4285266642 type Work @default.
• W4285266642 citedByCount "0" @default.
• W4285266642 crossrefType "journal-article" @default.
• W4285266642 hasAuthorship W4285266642A5021361572 @default.
• W4285266642 hasAuthorship W4285266642A5030304171 @default.
• W4285266642 hasAuthorship W4285266642A5036946045 @default.
• W4285266642 hasAuthorship W4285266642A5061330434 @default.
• W4285266642 hasAuthorship W4285266642A5076303798 @default.
• W4285266642 hasAuthorship W4285266642A5084634315 @default.
• W4285266642 hasBestOaLocation W42852666421 @default.
• W4285266642 hasConcept C126322002 @default.
• W4285266642 hasConcept C142052008 @default.
• W4285266642 hasConcept C142462285 @default.
• W4285266642 hasConcept C142724271 @default.
• W4285266642 hasConcept C151956035 @default.
• W4285266642 hasConcept C156957248 @default.
• W4285266642 hasConcept C1862650 @default.
• W4285266642 hasConcept C192489979 @default.
• W4285266642 hasConcept C2781413609 @default.
• W4285266642 hasConcept C2993143319 @default.
• W4285266642 hasConcept C3013748606 @default.
• W4285266642 hasConcept C44249647 @default.
• W4285266642 hasConcept C512399662 @default.
• W4285266642 hasConcept C71924100 @default.
• W4285266642 hasConceptScore W4285266642C126322002 @default.
• W4285266642 hasConceptScore W4285266642C142052008 @default.
• W4285266642 hasConceptScore W4285266642C142462285 @default.
• W4285266642 hasConceptScore W4285266642C142724271 @default.
• W4285266642 hasConceptScore W4285266642C151956035 @default.
• W4285266642 hasConceptScore W4285266642C156957248 @default.
• W4285266642 hasConceptScore W4285266642C1862650 @default.
• W4285266642 hasConceptScore W4285266642C192489979 @default.
• W4285266642 hasConceptScore W4285266642C2781413609 @default.
• W4285266642 hasConceptScore W4285266642C2993143319 @default.
• W4285266642 hasConceptScore W4285266642C3013748606 @default.
• W4285266642 hasConceptScore W4285266642C44249647 @default.
• W4285266642 hasConceptScore W4285266642C512399662 @default.
• W4285266642 hasConceptScore W4285266642C71924100 @default.
• W4285266642 hasLocation W42852666421 @default.
• W4285266642 hasLocation W42852666422 @default.
• W4285266642 hasLocation W42852666423 @default.
• W4285266642 hasOpenAccess W4285266642 @default.
• W4285266642 hasPrimaryLocation W42852666421 @default.
• W4285266642 hasRelatedWork W2037611947 @default.
• W4285266642 hasRelatedWork W2138334887 @default.
• W4285266642 hasRelatedWork W2218945907 @default.
• W4285266642 hasRelatedWork W2335988042 @default.

• next